- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Warner Chilcott PLC
+ Add to WatchlistWCRX:US
19.7550 USD 0.0650 0.33%As of 20:10:00 ET on 06/18/2013.
Snapshot for Warner Chilcott PLC (WCRX)
| Open: | 19.7600 | Day's Range: | 19.6400 - 19.8800 | Volume: | 3,437,537 |
|---|---|---|---|---|---|
| Previous Close: | 19.6900 | 52wk Range: | 10.8450 - 20.7500 | 1-Yr Rtn: | +45.23% |
Key Statistics for WCRX
| Current P/E Ratio (ttm) | 11.0584 |
|---|---|
| Estimated P/E(12/2013) | 5.8865 |
| Relative P/E vs. SPX | 0.6847 |
| Earnings Per Share (USD) (ttm) | 1.7864 |
| Est. EPS (USD) (12/2013) | 3.3560 |
| Est. PEG Ratio | 8.1193 |
| Market Cap (M USD) | 4,956.97 |
| Shares Outstanding (M) | 250.92 |
| 30 Day Average Volume | 10,593,808 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | 2.0034 |
| Dividend Indicated Gross Yield | 2.53% |
| Cash Dividend (USD) | 0.2500 |
| Last Dividend | 05/29/2013 |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/02/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for WCRX
Company Profile & Key Executives for WCRX
Warner Chilcott PLC is a pharmaceutical company. The Company is focused on marketing, selling, developing and manufacturing branded prescription pharmaceutical products in women's healthcare and dermatology in the United States.
| Roger M BoissonneaultPresident/CEO | W Carl ReichelPres:Pharmaceuticals |
| Paul S HerendeenExec VP/CFO | Anthony D BrunoExec VP:Corp Development |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
WCRX News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page